“This means . . . there should always be a way to maintain phage effectiveness, for example by alternating treatments,” explains Jason Clark, chief executive of Fixed Phage, a UK supplier. “You can’t do this with antibiotics.”
https://www.ft.com/content/c6df6bc4-f87e-4adb-bc92-97985f031550